Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local tranexamic acid during septoplasty for deviated nasal septum
ACTRN12625001186448Phase 4Completed
- Sponsor
- Damascus University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tranexamic acid in deviated nasal septum (DNS) (2 arms), sponsored by Damascus University. Primary endpoints: Total intraoperative blood loss, Quality of the surgical field and 1 more. Started Oct 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
deviated nasal septum (DNS)
Beyond the preview
Go deeper on ACTRN12625001186448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001186448.